by Murali Parthasarathy | May 22, 2023 | News, Company
Can you envision a world where precision medicine transforms healthcare as we know it? Tune in to this exciting episode of BioTalk with Rich Bendis, featuring Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions. In this enlightening discussion, Dr. Grammer unveils the...
by Murali Parthasarathy | May 19, 2023 | News, Company
CLICK TO VIEW ARTICLE > The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation, today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of...
by Murali Parthasarathy | May 18, 2023 | News, Company
CLICK TO READ ARTICLE > RICHMOND, VA – May 18, 2023 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the...
by Murali Parthasarathy | Apr 11, 2023 | Nephrology, News, Products
By Aayushi Pratap CLICK FOR ORIGINAL ARTICLE > NEW YORK – Precision medicine company AMPEL BioSolutions is developing a gene expression test that can predict kidney damage in patients with chronic kidney conditions such as lupus nephritis (LN). Charlottesville,...
by Murali Parthasarathy | Apr 3, 2023 | Company, News
Suzanne Youngkin shared the goals of the W+g initiative focused on wellbeing and workforce in Virginia during her March 30th visit to AMPEL BioSolutions, a women-owned business founded, headquartered and growing in Charlottesville. The focus of AMPEL’s business...
